BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ocimum Biosolutions Inc. Acquires New Distribution Partner for Spoligotyping Kits in Europe


11/8/2012 2:23:51 PM

Hyderabad, India, Nov 1st, 2012: Ocimed GmbH signed a distribution agreement for Ocimum Biosolutions’ research product Spoligotyping Kit. Preferred by customers in tuberculosis research, pharma companies, and in many other sectors, Spoligotyping Kit (spacer oligonucleotide typing kits) can detect and type Mycobacterium tuberculosis complex bacteria in clinical samples.

Ocimed GmbH, based in Friedberg/Hessen, Germany will distribute the kits in Europe. The internationally acclaimed research aid has customers in India as well as across the globe, especially in the United States and in Asia. While the kits have many buyers in Europe, this strategic move aims at increasing the customer base in that region while ensuring better quality of service to the existing customers.

Ms. Anu Acharya, CEO of Ocimum Biosolutions, said, “Our Spoligotyping Kit has been sold in more than 30 countries for over 10 years and has over 150 publications referencing it. With the growing threat of TB worldwide, we found that Ocimed with its focus in this area a very suitable partner.”.

About Ocimed:

Established in 2011, Ocimed is committed to providing products for better health in the European Union and across the globe. With 20+ years of expertise in the life sciences industry and extensive global contacts, they bring to their clients many value added products, services and solutions.

Their portfolio of services has four divisions. Medical devices division focuses on reselling innovative medical devices, all with the required certification. Research products division brings novel lab aids that give an edge to research. Consulting Services division works in collaboration with highly reputed organizations in the domain to provide services to meet research needs. Product Sourcing and Contract Development division works with vendors and clients across the globe to handle high volume requirements for raw materials, alternative medicines and other products.

About Ocimum Biosolutions:

Ocimum Biosolutions is a leading integrated global genomics outsourcing partner with solutions spanning Bioresearch Design and Execution; Data Analytics and Insights; Laboratory, Sample & Data Management; and Integrated Solutions. Ocimum provides comprehensive genomic services and reference databases; data analysis; life science lab information management solutions; and also offers both research level and GLP-compliant services. Majority of the top 25 pharma and biotech companies and leading research institutes worldwide have chosen Ocimum as their preferred genomics outsourcing partner. Ocimum has received several awards including “Bioinformatics Company of the Year” awards for 2010 and 2011, from BioSpectrum, “Fastest Growing Life Sciences Company in India”, Red Herring Asia 100, “IT Innovation Award” by NASSCOM and has been named in the Deloitte list of Fastest Growing companies in Asia, four years in a row.

For more information, please visit www3.ocimumbio.com

About Spoligotyping Kit:

Spoligotyping Kit is a simple, inexpensive, and effective tool for Tuberculosis/Mycobacterium research. This technique is highly useful for clinical samples as it can detect the causative bacteria and is capable of providing epidemiological information on strain identities. The specificity and sensitivity of this technique has been found to be 98% and 96% respectively with the clinical samples.

Spoligotyping is a RLB (Reversed Line Blotting) technique offers an alternative for typical Southern blotting when results are required. This is an efficient PCR-based method to simultaneously detect and type Mycobacterium tuberculosis complex bacteria in clinical samples (suspected nosocomial infections, outbreaks in prisons, etc.).



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES